# Levetiracetam offers a survival advantage in patients with epilepsy related to MGMT-unmethylated glioblastoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/levetiracetam-offers-a-survival-advantage-in-patients-with-epilepsy-related-to/

## Facts

| Field | Value |
| --- | --- |
| Author Names | L. Rojas,Alejandro Ruíz-Patiño,Andrés F. Cardona,Óscar Arrieta,Zyanya Lucía Zatarain-Barrón |
| Citations | 0 |
| DOI | 10.1093/annonc/mdx366.025 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://academic.oup.com/annonc/article-pdf/28/suppl_5/mdx366.025/19938937/mdx366.025.pdf |
| OpenAlex ID | https://openalex.org/W2763051724 |
| Type | article |
| Year | 2017 |

## Paper authors

- [L. Rojas](https://scholariq.org/researchers/l-rojas/)

## Paper journal

- [Annals of Oncology](https://scholariq.org/journals/annals-of-oncology/)

## Paper primary topic

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)

## Paper topics

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [Pharmacological Effects and Toxicity Studies](https://scholariq.org/topics/pharmacological-effects-and-toxicity-studies/)
- [Epilepsy research and treatment](https://scholariq.org/topics/epilepsy-research-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.